Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07027969Phase 4Not Yet Recruiting

Metabolic Surgery for Atrial Fibrillation Elimination

Role: lead

NCT06803888Phase 4Recruiting

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Role: lead

NCT02328599Completed

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Role: lead

NCT06374875Phase 4Recruiting

Fibrosis Lessens After Metabolic Surgery

Role: lead

NCT06355219Completed

Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines

Role: lead

All 5 trials loaded